Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology
Viatris(VTRS) Prnewswire·2024-12-18 19:59Viatris(VTRS) Prnewswire·2024-12-18 19:59
R1Viatris(VTRS) Prnewswire·2024-12-18 19:59 R1Viatris(VTRS) Prnewswire·2024-12-18 19:59